CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q1 2026 Earnings Call Transcript

CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q1 2026 Earnings Call Transcript May 7, 2026

CytomX Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.14.

Operator: Good afternoon, everyone. Thank you for standing by. Welcome to the CytomX Therapeutics First Quarter 2026 Financial Results Call. Please be advised that today’s conference is being recorded. I would now like to hand the call over to your host for today, Chris Ogden, CytomX’s Chief Financial...